We are delighted to announce that Buchang completed its A-share IPO on 18 November 2016. The Company listed on the main board of the Shanghai Stock Exchange under the ticker symbol 603858. A link to the news story on the Company’s website can be found here and a link to Buchang’s share price quote can be found here (Bloomberg).
About Buchang Pharmaceuticals
Buchang Pharmaceuticals is one of the leading traditional Chinese medicine (TCM) companies in China. Buchang was founded in 1993 by Mr. Zhao Buchang and his eldest son, Mr. Zhao Tao. Starting as a small TCM drug manufacturer, Buchang has evolved into a sales and marketing powerhouse. The Company has the most extensive sales network amongst its peers in China, covering over 15,000 hospitals and 150,000 drug stores. The Company’s product portfolio consists of in-house developed products, as well as products that it acquired and turned into blockbusters. Buchang’s brand name is widely recognized by physicians and patients throughout China.